Upcoming Events

Feb. 27:  Go Global Med Tech

Mar. 14:  WBBA's Pub Night- March

Mar. 28:  From the Laboratory to Leadership - Spring 2012

Mar. 28:  NeuroNEXT at Swedish Neuroscience Institute

View all upcoming events View the Community Calendar
View the 2012 WBBA event calendar (pdf) Submit your event to the Community Calendar
Secure your 2012 sponsorship. View the prospectus online!

 Breaking News and Announcements 

Loading....

 

"Economic Issues in WA Healthcare” Breaking News powered by

Archived News and Announcements

About WBBA

The Washington Biotechnology & Biomedical Association (WBBA) is an independent, non-profit 501(c)(6) trade association serving the life sciences industry in the state of Washington. Our members include organizations engaged in, or supportive of, research, development and commercialization of life science technologies.

Our Mission: Innovation to Realization… supporting breakthrough discoveries that create better health solutions.

More about WBBA

Member Center

Focusing on the needs of our members and delivering value.

Public Policy

Leading advocate for advancing Washington state's life sciences.

Commercialization

Bridging the gap between discovery and commercialization.

Chairman's Circle

 

 

 

 

Amgen

 Fenwick & West LLP

 

 

 

 

 

Lilly USA LLC

                         

Platinum Leaders


Gilead


 

Philips Ultrasound

 Praxair Specialty Gases

 

Washington State University

                 

WYNDHAM PUBLICATIONS, INC.

  Gold Leaders

 

Member News Spotlight

Stratos Product Development Lends Critical Design Expertise to Mimic Technologies' dV-Trainer Surgical Training Device | Press Release
Study shows an investigational urine test can predict high-risk prostate cancer in men who choose ‘watchful waiting’ | Press Release
A CEO's Guide to Innovation in China | McKinsey Quarterly
Physio-Control Completes Sale to Bain Capital
Brian Webster Assumes Role of Chief Executive Officer | Press Release
Omeros leases space at Waterfront Research Center | Puget Sound Business Journal
Novo Nordisk establishes type 1 diabetes R&D center in Seattle | Press Release
Janssen Healthcare Innovation Announces Connected Care Challenge: Providing awards totaling $250,000 to inspire and nurture the best solutions to improve patient transitions from hospital to home | Announcement
CompleGen Announces Successful Delivery of Its XenoGene™ Technology to Boehringer Ingelheim for Drug Discovery Under a Non-Exclusive Agreement  | Announcement

Purchasing Program


Career Center

WBBA Career Center

Support WBBA with your Amazon.com Purchases


© 2011 Washington Biotechnology & Biomedical Association
        
Powered by Affiniscape - Web Content and Association Membership Management